The overall goal of the Neuropathology Core (Core D) is to collect, characterize, store, and distribute well-characterized brains from autopsy participants from the Clinical Core, consisting of a group of well-documented individuals with Alzheimer disease (AD) and from normal control individuals without neurological disease. Specific Core D aims are: 1) diagnostic neuropathological evaluation of each brain, using a meticulous diagnostic approach, essential to all studies related to and stemming from these subjects. A standardardized approach for neuropathologic assessment is performed using published diagnostic criteria for those brains with recognizable neurodegenerative diseases. Neuropathological diagnosis of Alzheimer disease is based on NIA-Reagan Institute criteria. Other neurodegenerative diseases, coexistent with or instead of AD, will be evaluated by currently available published criteria. 2) Tissue preparation for research, collaboration. Processing and storing tissue from each brain and skeletal muscle sample collected will be performed for subsequent distribution to KU ADCC and other approved investigators to support AD-related research. Core D will contribute neuropathology case information to the NACC database. In order to assist investigators studying animal models of AD and related disorders, neuropathology services provided for study of human tissues will also be made available for animal-based researchers. Core D will also investigate new techniques and products for enhancing tissue preservation related to the proposed studies emphasized by this ADC. There is excellent integration with the other Cores, ranging from provision of tissue for genetic, metabolic studies (MGM Core), clinicopathological correlations (Clinical, Neuroimaging, Education Cores), centralization of data (Data Management Core), reviewing tissue requests (Administration Core), to community and resident education (Education Core). As new criteria for neuropathological assessments, new methodologies, and feedback from the other cores and the AD-neurodegenerative field occurs. Core D will show adaptability in order to implement change in assessments of the brains.

Public Health Relevance

In studies of AD, it is important to correlate clinical and peripheral biospecimen data with brain pathological changes. These studies may contribute to biomarker development, additional insights into AD pathogenesis, and evaluation of response or adverse effects due to therapeutic interventions.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG035982-03
Application #
8501216
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
3
Fiscal Year
2013
Total Cost
$143,106
Indirect Cost
$47,702
Name
University of Kansas
Department
Type
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Menta, Blaise W; Swerdlow, Russell H (2018) An Integrative Overview of Non-Amyloid and Non-Tau Pathologies in Alzheimer's Disease. Neurochem Res :
Deng, Yue; Jiang, Beichen; Rankin, Carolyn L et al. (2018) Methionine sulfoxide reductase A (MsrA) mediates the ubiquitination of 14-3-3 protein isotypes in brain. Free Radic Biol Med 129:600-607
Ptomey, Lauren T; Szabo, Amanda N; Willis, Erik A et al. (2018) Remote Exercise for Adults with Down Syndrome. Transl J Am Coll Sports Med 3:60-65
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Perales, Jaime; Hinton, Ladson; Burns, Jeffrey et al. (2018) Cardiovascular health and cognitive function among Mexican older adults: cross-sectional results from the WHO Study on Global Ageing and Adult Health. Int Psychogeriatr 30:1827-1836
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Perales, Jaime; Moore, W Todd; Fernandez, Cielo et al. (2018) Feasibility of an Alzheimer's disease knowledge intervention in the Latino community. Ethn Health :1-12
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Gupta, Aditi; Thomas, Tashra S; Klein, Jeffrey A et al. (2018) Discrepancies between Perceived and Measured Cognition in Kidney Transplant Recipients: Implications for Clinical Management. Nephron 138:22-28

Showing the most recent 10 out of 333 publications